SweetValueLab
Write for us

Mettler-Toledo International Inc. — Wall Street Analyst Estimates & Price Targets

MTD
NYSEHealthcareMedical - Diagnostics & ResearchCIK 0001037646mt.comAbout MTD
Last close · Oct 16, 20261,622.29−16.75 (−1.02%)
Market cap$32.5B

5 firms' latest targets, last 90 days: median $1,580.00 ($1,515.00–$1,700.00), 3% below the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$1,000$1,200$1,400$1,600NovJan 2026MarMayJulSep2025-12-01 · Morgan Stanley: $1,5502025-12-09 · Goldman Sachs: $1,4752025-12-15 · Wells Fargo: $1,4502025-12-15 · Susquehanna: $1,6002025-12-15 · Barclays: $1,5502026-02-09 · Morgan Stanley: $1,4752026-02-09 · Baird: $1,4452026-04-14 · Barclays: $1,5002026-05-11 · Baird: $1,1942026-05-18 · Stifel: $1,4002026-07-06 · Evercore ISI: $1,3502026-07-31 · Jefferies: $1,5802026-08-03 · Barclays: $1,5752026-08-03 · Stifel: $1,6002026-08-04 · Morgan Stanley: $1,4502026-09-01 · RBC Capital: $1,5152026-10-07 · Barclays: $1,7002026-10-12 · Morgan Stanley: $1,575
$1,000$1,200$1,400$1,600NovFebMayAug

Each firm's latest target

last 90 days · 5 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-12Morgan Stanley$1,575.00$1,450.00▲ 9%+1%-3%
2026-10-07Barclays$1,700.00$1,575.00▲ 8%+11%+5%
2026-09-01RBC Capital$1,515.00——+8%-7%
2026-08-03Stifel$1,600.00$1,400.00▲ 14%+13%-1%
2026-07-31Jefferies$1,580.00——+12%-3%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2023reported$3.8B-3%$35.90-7%est. $3.8B-1%est. $38.808
2024reported$3.9B+2%$40.48+13%est. $3.8B+1%est. $40.458
2025reported$4.0B+4%$42.05+4%est. $4.0B+1%est. $42.198
2026$4.2B+5%$47.34+12%$4.2B–$4.3B$47.23–$47.5210
2027$4.4B+5%$51.70+9%$4.4B–$4.5B$51.28–$51.9810
2028$4.7B+5%$57.21+11%$4.6B–$4.7B$55.83–$59.289
2029$4.9B+5%$63.68+11%$4.9B–$4.9B$63.24–$64.174
2030$5.1B+5%$71.24+12%$5.1B–$5.2B$70.75–$71.804
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.